3-123734196-G-T

Variant summary

Our verdict is Likely benign. The variant received -3 ACMG points: 0P and 3B. BP4_ModerateBP6

The NM_053025.4(MYLK):​c.800C>A​(p.Thr267Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000104 in 1,543,152 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. T267T) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0000066 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000011 ( 0 hom. )

Consequence

MYLK
NM_053025.4 missense

Scores

1
18

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:1

Conservation

PhyloP100: 0.0960

Publications

0 publications found
Variant links:
Genes affected
MYLK (HGNC:7590): (myosin light chain kinase) This gene, a muscle member of the immunoglobulin gene superfamily, encodes myosin light chain kinase which is a calcium/calmodulin dependent enzyme. This kinase phosphorylates myosin regulatory light chains to facilitate myosin interaction with actin filaments to produce contractile activity. This gene encodes both smooth muscle and nonmuscle isoforms. In addition, using a separate promoter in an intron in the 3' region, it encodes telokin, a small protein identical in sequence to the C-terminus of myosin light chain kinase, that is independently expressed in smooth muscle and functions to stabilize unphosphorylated myosin filaments. A pseudogene is located on the p arm of chromosome 3. Four transcript variants that produce four isoforms of the calcium/calmodulin dependent enzyme have been identified as well as two transcripts that produce two isoforms of telokin. Additional variants have been identified but lack full length transcripts. [provided by RefSeq, Jul 2008]
MYLK Gene-Disease associations (from GenCC):
  • aortic aneurysm, familial thoracic 7
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • familial thoracic aortic aneurysm and aortic dissection
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • megacystis-microcolon-intestinal hypoperistalsis syndrome 1
    Inheritance: AR Classification: STRONG Submitted by: G2P
  • connective tissue disorder
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • megacystis-microcolon-intestinal hypoperistalsis syndrome
    Inheritance: AD, AR Classification: SUPPORTIVE, LIMITED Submitted by: Orphanet, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -3 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.070908755).
BP6
Variant 3-123734196-G-T is Benign according to our data. Variant chr3-123734196-G-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 547553.We mark this variant Likely_benign, oryginal submission is: [Conflicting_classifications_of_pathogenicity].

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MYLKNM_053025.4 linkc.800C>A p.Thr267Asn missense_variant Exon 10 of 34 ENST00000360304.8 NP_444253.3 Q15746-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MYLKENST00000360304.8 linkc.800C>A p.Thr267Asn missense_variant Exon 10 of 34 5 NM_053025.4 ENSP00000353452.3 Q15746-1

Frequencies

GnomAD3 genomes
AF:
0.00000660
AC:
1
AN:
151624
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000156
AC:
3
AN:
192284
AF XY:
0.00000974
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000213
Gnomad OTH exome
AF:
0.000210
GnomAD4 exome
AF:
0.0000108
AC:
15
AN:
1391528
Hom.:
0
Cov.:
53
AF XY:
0.0000116
AC XY:
8
AN XY:
687010
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
31442
American (AMR)
AF:
0.00
AC:
0
AN:
36592
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
22310
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39124
South Asian (SAS)
AF:
0.0000133
AC:
1
AN:
75438
European-Finnish (FIN)
AF:
0.0000267
AC:
1
AN:
37408
Middle Eastern (MID)
AF:
0.000184
AC:
1
AN:
5440
European-Non Finnish (NFE)
AF:
0.0000110
AC:
12
AN:
1086086
Other (OTH)
AF:
0.00
AC:
0
AN:
57688
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.465
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00000660
AC:
1
AN:
151624
Hom.:
0
Cov.:
32
AF XY:
0.0000135
AC XY:
1
AN XY:
74032
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41206
American (AMR)
AF:
0.00
AC:
0
AN:
15230
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5156
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4800
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10488
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.0000147
AC:
1
AN:
67956
Other (OTH)
AF:
0.00
AC:
0
AN:
2094
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.575
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.0000869
Hom.:
0
Bravo
AF:
0.00000756
ExAC
AF:
0.00000826
AC:
1

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Aortic aneurysm, familial thoracic 7 Uncertain:1
Mar 05, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces threonine, which is neutral and polar, with asparagine, which is neutral and polar, at codon 267 of the MYLK protein (p.Thr267Asn). This variant is present in population databases (rs755451013, gnomAD 0.002%). This variant has not been reported in the literature in individuals affected with MYLK-related conditions. ClinVar contains an entry for this variant (Variation ID: 547553). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt MYLK protein function with a negative predictive value of 95%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Familial thoracic aortic aneurysm and aortic dissection Uncertain:1
Jun 23, 2021
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The p.T267N variant (also known as c.800C>A), located in coding exon 7 of the MYLK gene, results from a C to A substitution at nucleotide position 800. The threonine at codon 267 is replaced by asparagine, an amino acid with similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -

Connective tissue disorder Benign:1
Nov 01, 2016
Center for Human Genetics, Inc, Center for Human Genetics, Inc
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.26
BayesDel_addAF
Benign
-0.28
T
BayesDel_noAF
Benign
-0.60
CADD
Benign
8.2
DANN
Benign
0.70
DEOGEN2
Benign
0.20
.;.;.;T;.;T
Eigen
Benign
-0.90
Eigen_PC
Benign
-0.89
FATHMM_MKL
Benign
0.078
N
LIST_S2
Benign
0.81
.;T;T;T;.;.
M_CAP
Benign
0.024
T
MetaRNN
Benign
0.071
T;T;T;T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.55
N;N;N;N;N;N
PhyloP100
0.096
PrimateAI
Benign
0.29
T
PROVEAN
Benign
-0.75
N;.;N;N;N;N
REVEL
Benign
0.045
Sift
Benign
0.043
D;.;D;D;T;D
Sift4G
Uncertain
0.028
D;D;D;D;D;D
Polyphen
0.050
B;B;B;B;B;B
Vest4
0.16
MutPred
0.28
Gain of ubiquitination at K265 (P = 0.0764);Gain of ubiquitination at K265 (P = 0.0764);Gain of ubiquitination at K265 (P = 0.0764);Gain of ubiquitination at K265 (P = 0.0764);Gain of ubiquitination at K265 (P = 0.0764);Gain of ubiquitination at K265 (P = 0.0764);
MVP
0.56
MPC
0.25
ClinPred
0.040
T
GERP RS
2.2
Varity_R
0.072
gMVP
0.070
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs755451013; hg19: chr3-123453043; API